Known targets — ChEMBL curated mechanism
ADRA1AADRA1BADRA1DADRB1ADRB2ADRB3CYP11B1DPP4FGFR1FGFR2FGFR3FGFR4HRH1JAK1JAK2JAK3KCNA1KCNA10KCNA2KCNA3KCNA4KCNA5KCNA6KCNA7KCNB1KCNB2KCNC1KCNC2KCNC3KCNC4KCND1KCND2KCND3KCNF1KCNG1KCNG2KCNG3KCNG4KCNH1KCNH2KCNH3KCNH4KCNH5KCNH6KCNH7KCNH8KCNQ1KCNQ2KCNQ3KCNQ4KCNQ5KCNS1KCNS2KCNS3KCNV1KCNV2KDRKITNAOPRD1OPRK1OPRM1PPDGFRBPIK3CDSCN10ASCN11ASCN1ASCN2ASCN3ASCN4ASCN5ASCN7ASCN8ASCN9ASMOTYK2polrplArplBrplCrplDrplErplFrplJrplKrplLrplMrplNrplOrplPrplQrplRrplSrplTrplUrplVrplWrplXrplYrpmArpmBrpmCrpmDrpmErpmFrpmGrpmHrpmIrpmJrpsArpsBrpsCrpsDrpsErpsFrpsGrpsHrpsIrpsJrpsKrpsLrpsMrpsNrpsOrpsPrpsQrpsRrpsSrpsTrpsUykgMykgO
The experimentally established mechanism targets of Phosphoric Acid. The predicted profile below is derived independently by chemical similarity — agreement is a validation signal, a miss is honest.
Predicted protein targets (top 17)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | LMNA | P02545 | 4/20 | 0.43 |
| ▸ | SLC34A1 | Q06495 | 1/20 | 0.42 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.35 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.35 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.35 |
| ▸ | CA1 | P00915 | 2/20 | 0.33 |
| ▸ | CA4 | P22748 | 2/20 | 0.33 |
| ▸ | CA5A | P35218 | 2/20 | 0.33 |
| ▸ | CA5B | Q9Y2D0 | 2/20 | 0.33 |
| ▸ | BLM | P54132 | 1/20 | 0.32 |
| ▸ | PMP22 | Q01453 | 1/20 | 0.32 |
| ▸ | CYP2C9 | P11712 | 1/20 | 0.32 |
| ▸ | TSHR | P16473 | 1/20 | 0.32 |
| ▸ | ALOX12 | P18054 | 1/20 | 0.32 |
| ▸ | NFKB1 | P19838 | 1/20 | 0.32 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.32 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.32 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Phosphoric Acid SCHEMBL8678542 | 1.00 | LMNA (0.43) | LMNASLC34A1KDM4ECYP2C19KMT2A | |
| Phosphoric Acid SCHEMBL28087305 | 0.94 | LMNA (0.40) | LMNASLC34A1KDM4ECYP2C19KMT2A | |
| Phosphoric Acid SCHEMBL14054546 | 0.94 | SLC34A1 (0.50) | LMNASLC34A1KDM4ECYP2C19KMT2A | |
| Phosphoric Acid SCHEMBL3973002 | 0.94 | — | — | |
| Phosphoric Acid SCHEMBL28093030 | 0.94 | LMNA (0.40) | LMNASLC34A1KDM4ECYP2C19KMT2A | |
| Phosphoric Acid SCHEMBL9769970 | 0.94 | SLC34A1 (0.50) | LMNASLC34A1KDM4ECYP2C19KMT2A | |
| Phosphoric Acid SCHEMBL5789473 | 0.94 | — | — | |
| Phosphoric Acid SCHEMBL27542549 | 0.94 | LMNA (0.40) | LMNASLC34A1KDM4ECYP2C19KMT2A | |
| Phosphoric Acid SCHEMBL1311 | 0.94 | — | — | |
| Phosphoric Acid SCHEMBL262002 | 0.94 | LMNA (0.46) | LMNASLC34A1KDM4ECYP2C19KMT2A |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 130 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-119930723-A | Method for extracting adenine phosphate in Cordyceps militaris | 博斯创想(上海)医疗科技有限公司 | 2025-05-06 | — | — | CN | claimed |
| CN-116710465-A | Adenosine derivatives and pharmaceutical compositions containing the same | 腾盛博药生物科技有限公司 | 2023-09-05 | — | — | CN | claimed |
| CN-105084589-A | Treatment method and system for wet magnesium desulphurization wastewater | HUATIAN ENG & TECH CORP MCC | 2015-11-25 | — | — | CN | claimed |
| CN-103071146-A | Caspofungin acetate composition and preparation method thereof | BEIJING JESKONT PHARMACEUTICAL INTERNAT CO LTD | 2013-05-01 | — | — | CN | claimed |
| WO-2009002055-A1 | MANUFACTURING METHOD OF DIESEL USING WASTE CORN OIL | VODUSTM CO.,LTD (KR) | 2008-12-31 | — | — | WO | claimed |
| CN-101328419-A | Method for producing diesel fuel with waste edible oil | BINGYU YU (CN) | 2008-12-24 | — | — | CN | claimed |
| US-6835375-B2 | Mixture containing nonionic surfactant, silicone and polymers | SAN-EI KAGAKU CO., LTD. (JP) | 2004-12-28 | — | — | US | claimed |
| US-4102981-A | Removal of acidic impurity from chlorofluoromethanes | KAISER ALUMINUM & CHEMICAL CORPORATION (US) | 1978-07-25 | — | — | US | claimed |
| JP-8271512-A | — | — | None | — | — | JP | disclosed |
| CN-119978110-A | Recombinant type 17 collagen with transdermal effect and preparation method and application thereof | 广州市暨源生物科技有限公司 | 2025-05-13 | — | — | CN | disclosed |
| CN-119930723-A | Method for extracting adenine phosphate in Cordyceps militaris | 博斯创想(上海)医疗科技有限公司 | 2025-05-06 | — | — | CN | disclosed |
| CN-117839310-A | Method for removing collecting agent by one-step ammonia dissolution of tungstic acid | 崇义章源钨业股份有限公司 | 2024-04-09 | — | — | CN | disclosed |
| US-20240082203-A1 | PHARMACEUTICAL COMPOSITION FOR INHALATION | Shanghai Huilun Pharmaceutical Co., Ltd. (CN) | 2024-03-14 | — | — | US | disclosed |
| CN-115998761-B | Antiallergic rhinitis composition and preparation method and application thereof | 湖南天根乐微君科技有限公司 | 2024-02-06 | — | — | CN | disclosed |
| US-4026710-A | Preparation of zinc flake coating composition | DIAMOND SHAMROCK CORPORATION (US) | 1977-05-31 | — | — | US | disclosed |
| US-4020220-A | Composite coating having enhanced corrosion resistance | DIAMOND SHAMROCK CORPORATION (US) | 1977-04-26 | — | — | US | disclosed |
| US-3990920-A | CHROMIC ACID AND PULVERULENT ZINC AS COATINGS | DIAMOND SHAMROCK CORPORATION (US) | 1976-11-09 | — | — | US | disclosed |
| US-3970482-A | ZINC CONTAINING COATING | DIAMOND SHAMROCK CORPORATION (US) | 1976-07-20 | — | — | US | disclosed |
| US-3954510-A | Metal treating compositions of controlled pH | DIAMOND SHAMROCK CORPORATION (US) | 1976-05-04 | — | — | US | disclosed |
| US-3940280-A | Concentrate for liquid coating composition for metal substrates | DIAMOND SHAMROCK CORPORATION (US) | 1976-02-24 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20240082203-A1 | PHARMACEUTICAL COMPOSITION FOR INHALATION | AQP1, H4C1; H4C2; H4C3; H4C4; H4C5; H4C6; H4C8; H4C9; H4C11; H4C12; H4C13; H4C14; H4C15; H4C16, AQP4 | LMNA 4412/4885SLC34A1 586/4885KDM4E 2631/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.